These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15261229)

  • 41. Dutch myotonic dystrophy type 2 patients and a North-African DM2 family carry the common European founder haplotype.
    Coenen MJ; Tieleman AA; Schijvenaars MM; Leferink M; Ranum LP; Scheffer H; van Engelen BG
    Eur J Hum Genet; 2011 May; 19(5):567-70. PubMed ID: 21224892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Proximal myotonial myopathy (PROMM): clinical and histology study].
    Bassez G; Attarian S; Laforêt P; Azulay JP; Rouche A; Ferrer X; Urtizberea JA; Pellissier JF; Duboc D; Fardeau M; Pouget J; Eymard B
    Rev Neurol (Paris); 2001 Feb; 157(2):209-18. PubMed ID: 11283467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe dilated cardiomyopathy in a patient with myotonic dystrophy type 2 and homozygous repeat expansion in ZNF9.
    Lee TM; Maurer MS; Karbassi I; Braastad C; Batish SD; Chung WK
    Congest Heart Fail; 2012; 18(3):183-6. PubMed ID: 22587749
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical and genetic heterogeneity in myotonic dystrophies.
    Meola G
    Muscle Nerve; 2000 Dec; 23(12):1789-99. PubMed ID: 11102902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2).
    Meola G; Sansone V; Perani D; Scarone S; Cappa S; Dragoni C; Cattaneo E; Cotelli M; Gobbo C; Fazio F; Siciliano G; Mancuso M; Vitelli E; Zhang S; Krahe R; Moxley RT
    Neuromuscul Disord; 2003 Dec; 13(10):813-21. PubMed ID: 14678804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study.
    Kassubek J; Juengling FD; Hoffmann S; Rosenbohm A; Kurt A; Jurkat-Rott K; Steinbach P; Wolf M; Ludolph AC; Lehmann-Horn F; Lerche H; Weber YG
    Neurosci Lett; 2003 Sep; 348(2):73-6. PubMed ID: 12902021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uninterrupted CCTG tracts in the myotonic dystrophy type 2 associated locus.
    Radvanszky J; Surovy M; Polak E; Kadasi L
    Neuromuscul Disord; 2013 Jul; 23(7):591-8. PubMed ID: 23561036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Late-Onset Proximal Myotonic Myopathy (PROMM): A Rare Presentation in an Adult.
    Deolikar V; Saboo K; Kumar S; Acharya S; Chavan S
    Cureus; 2023 Dec; 15(12):e50711. PubMed ID: 38234939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absence of a differentiation defect in muscle satellite cells from DM2 patients.
    Pelletier R; Hamel F; Beaulieu D; Patry L; Haineault C; Tarnopolsky M; Schoser B; Puymirat J
    Neurobiol Dis; 2009 Oct; 36(1):181-90. PubMed ID: 19632331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Linkage of proximal myotonic myopathy to chromosome 3q.
    Ricker K; Grimm T; Koch MC; Schneider C; Kress W; Reimers CD; Schulte-Mattler W; Mueller-Myhsok B; Toyka KV; Mueller CR
    Neurology; 1999 Jan; 52(1):170-1. PubMed ID: 9921867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repeat-primed polymerase chain reaction in myotonic dystrophy type 2 testing.
    Radvansky J; Ficek A; Kadasi L
    Genet Test Mol Biomarkers; 2011 Mar; 15(3):133-6. PubMed ID: 21204698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Myotonic dystrophy type 2].
    Kimura T
    Rinsho Shinkeigaku; 2012; 52(11):1267-9. PubMed ID: 23196585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PROMM: the expanding phenotype. A family with proximal myopathy, myotonia and deafness.
    Phillips MF; Rogers MT; Barnetson R; Braun C; Harley HG; Myring J; Stevens D; Wiles CM; Harper PS
    Neuromuscul Disord; 1998 Oct; 8(7):439-46. PubMed ID: 9829272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands.
    Udd B; Meola G; Krahe R; Thornton C; Ranum L; Day J; Bassez G; Ricker K
    Neuromuscul Disord; 2003 Sep; 13(7-8):589-96. PubMed ID: 12921797
    [No Abstract]   [Full Text] [Related]  

  • 55. Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2.
    Young NP; Daube JR; Sorenson EJ; Milone M
    Muscle Nerve; 2010 Jun; 41(6):758-62. PubMed ID: 20513102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro.
    Ursu SF; Alekov A; Mao NH; Jurkat-Rott K
    Acta Myol; 2012 Oct; 31(2):144-53. PubMed ID: 23097607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2.
    Merlini L; Sabatelli P; Columbaro M; Bonifazi E; Pisani V; Massa R; Novelli G
    Muscle Nerve; 2005 Jun; 31(6):764-7. PubMed ID: 15704146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A pedigree with myotonic dystrophy: non-CTG, non-CCTG repeat expansion].
    Zhao XP; Xie HJ; Zheng HM; Yu ZL; Cui Y; Ding SJ; Ren DM; Tang GM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):459-62. PubMed ID: 15476170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
    Kumar A; Agarwal S; Agarwal D; Phadke SR
    Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Proximal myotonic myopathy (PROMM). Clinical variability within a family].
    Eger K; Schulte-Mattler WJ; Zierz S
    Nervenarzt; 1997 Oct; 68(10):839-44. PubMed ID: 9441258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.